Japanese researchers have decoded 20 near-complete genetic variant groups hidden in disease and immune-related regions of the human genome, moving the global effort to map all human genetic diversity decisively forward.
This breakthrough matters because our understanding of human genetics has long been built on a foundation of incompleteness. Traditional reference genomes, relied upon by scientists worldwide for nearly two decades, were constructed from a limited number of individuals and didn't capture the full spectrum of genetic variations that differ across populations. These missing variants—groups of genes inherited from one parent that can influence disease susceptibility or immune response—are precisely the ones that shape how illness develops and progresses. For Japanese populations and other groups historically underrepresented in genomic research, this gap has meant less precise diagnosis and treatment.
A team led by Yoshihiko Suzuki at the Research Organization of Information and Systems tackled this challenge using a pangenome graph approach, which weaves together genetic sequences from multiple individuals into a unified system. Rather than treating the genome as a single linear blueprint, the pangenome graph reveals how genetic sequences overlap, diverge, and recombine across people—making it possible to identify variants that conventional methods miss. Working with samples from 10 Japanese men, the researchers systematically reconstructed previously unresolved regions that conventional genomes couldn't adequately represent.
The results, published May 27 in Nature Communications, are striking. The team nearly doubled the complete reconstruction rate of complex genetic regions from 46.8% to 91.2%, revealing new genomic structures and mutation patterns along the way. In the KIR region on chromosome 19, for example, they discovered that Japanese haplotypes possess substantially different structures than the linear reference genome—including previously unidentified gene configurations. The pangenome graph made visible what had been invisible: the actual diversity encoded in Japanese DNA that global reference genomes had failed to capture.
This contribution arrives at a pivotal moment for genomic science. Since the international Telomere-to-Telomere Consortium completed the first full reference human genome in 2022, the race has intensified to create a comprehensive pangenome that genuinely represents human genetic variation across populations. Japan's contribution fills critical gaps, particularly in complex regions where traditional sequencing methods tend to fail—places where genes repeat or resemble each other so closely that they're difficult to distinguish and assemble correctly.
The implications ripple across medicine and public health. Understanding how genetic diversity actually maps onto disease risk in specific populations opens pathways toward more personalized medicine and more equitable healthcare. A treatment protocol based on a genome that didn't represent Japanese genetic variation might miss important molecular differences in how disease manifests or responds to therapy. By anchoring genomic medicine in genuine population diversity rather than incomplete reference sequences, researchers can develop diagnostics and treatments better calibrated to the people who need them.
"We increased the complete reconstruction rate of complex genetic regions related to immunity and disease from the previous 46.8% to 91.2%, and we revealed new genomic sequence structures as well as mutation patterns suggesting bias in the evolutionary process," Suzuki noted. The work now provides a foundation for deeper investigation into how evolution has shaped immune and disease-related genes differently across human populations—knowledge that will inform the next phase of pangenome research as scientists worldwide race to ensure no population's genetic story remains untold.